Showing results (151-160 of 391) with videos related to

Sort By:
Pageof 40
Clinical Endocrinology|November 1, 1990
Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndromeG S Conway, H S Jacobs, J M Holly, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1999
Human leukocyte antigen-DQB1* genotypes encoding aspartate at position 57 are associated with 3beta-hydroxysteroid dehydrogenase autoimmunity in premature ovarian failureS Arif, J A Underhill, P Donaldson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2012
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection techniqueDevon S Conway, Deborah M Miller, Ralph G O'Brien, et al.
Clinical Endocrinology|September 1, 1999
Lipid profile, glucose tolerance and insulin sensitivity after more than four years of growth hormone therapy in non-growth hormone deficient adolescentsP Bareille, C Azcona, D R Matthews, et al.
The American Journal of Physiology|February 1, 1988
Spatial heterogeneity of local blood flow and metabolite content in dog heartsD Franzen, R S Conway, H Zhang, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1993
Effect of ethanol exposure on circulating levels of insulin-like growth factor I and II, and insulin-like growth factor binding proteins in fetal ratsH J Mauceri, T Unterman, S Dempsey, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 31, 1993
A clinical evaluation of a direct radioimmunoassay of testosteroneP Holownia, G S Conway, U Shrivastava, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 20, 2005
XY females: revisiting the diagnosisCatherine L Minto, Naomi S Crouch, Gerard S Conway, et al.
Phytopathology|October 24, 2008
Relationship Between Host Acidification and Virulence of Penicillium spp. on Apple and Citrus FruitDov Prusky, James L McEvoy, Robert Saftner, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 18, 2020
Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis populationDevon S Conway, Carrie M Hersh, Haleigh C Harris, et al.
Pageof 40